# Assessment of the Biodistribution and Safety of [18F]MNI-958 in Healthy Subjects

> **NCT03472313** · PHASE1 · COMPLETED · sponsor: **Invicro** · enrollment: 2 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** [18F]MNI-958

## Key facts

- **NCT ID:** NCT03472313
- **Lead sponsor:** Invicro
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-14
- **Primary completion:** 2018-04-20
- **Final completion:** 2018-04-20
- **Target enrollment:** 2 (ACTUAL)
- **Last updated:** 2018-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03472313

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03472313, "Assessment of the Biodistribution and Safety of [18F]MNI-958 in Healthy Subjects". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT03472313. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*